Virtual screening: An overview on methods and applications

Handbook of Research on Computational and Systems Biology: Interdisciplinary Applications

Volumn , Issue , 2011, Pages 28-60

  Barakat, Khaled H ^a   Mane, Jonathan Y ^a   Tuszynski, Jack A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898158901     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4018/978-1-60960-491-2.ch002     Document Type: Chapter

References (120)

1. Abagyan, R., & Totrov, M. (2001). High-throughput docking for lead generation. Current Opinion in Chemical Biology, 5(4), 375-382. doi:10.1016/S1367-5931(00)00217-9
2. Aqvist, J., Medina, C., & Samuelsson, J. E. (1994). A new method for predicting binding affinity in computer-aided drug design. Protein Engineering, 7(3), 385-391. doi:10.1093/protein/7.3.385
3. Barakat, K., Mane, J., Friesen, D., & Tuszynski, J. (2009). Ensemble-based virtual screening reveals dual-inhibitors for the p53-MDM2/MDMX interactions. Journal of Molecular Graphics Models.
4. Barakat, K. H., Torin Huzil, J., Luchko, T., Jordheim, L., Dumontet, C., & Tuszynski, J. (2009). Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach. Journal of Molecular Graphics & Modelling, 28(2), 113-130. doi:10.1016/j.jmgm.2009.04.009
5. Barnum, D., Greene, J., Smellie, A., & Sprague, P. (1996). Identification of common functional configurations amongmolecules. Journal of Chemical Information and Computer Sciences, 36(3), 563-571. doi:10.1021/ci950273r
6. Baxter, C.A., Murray, C.W., Clark, D. E., Westhead, D. R., & Eldridge, M. D. (1998). Flexible docking usingTabu search and an empirical estimate of binding affinity. Proteins, 33(3), 367-382. doi:10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO;2-W
7. Bender, A., Jenkins, J. L., Scheiber, J., Sukuru, S. C., Glick, M., & Davies, J. W. (2009). How similar are similarity searching methods? A principal component analysis of molecular descriptor space. Journal of Chemical Information and Modeling, 49(1), 108-119. doi:10.1021/ci800249s
8. Betzi, S., Restouin, A., Opi, S., Arold, S. T., Parrot, I., & Guerlesquin, F. (2007). Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening:Application to the HIV-1 Nef protein. Proceedings of the National Academy of Sciences of the United States of America, 104(49), 19256-19261. doi:10.1073/pnas.0707130104
9. Bissantz, C., Folkers, G., & Rognan, D. (2000). Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. Journal of Medicinal Chemistry, 43(25), 4759-4767. doi:10.1021/jm001044l
10. Bohm, H. J. (1992). The computer program LUDI: A new method for the de novo design of enzyme inhibitors. Journal of Computer-Aided Molecular Design, 6(1), 61-78. doi:10.1007/BF00124387
11. Brenk, R., Naerum, L., Gradler, U., Gerber, H. D., Garcia, G. A., & Reuter, K. (2003). Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis. Journal of Medicinal Chemistry, 46(7), 1133-1143. doi:10.1021/jm0209937
12. Broughton, H.B. (2000). A method for including protein flexibility in protein-ligand docking: improving tools for database mining and virtual screening. Journal of Molecular Graphics Models, 18(3), 247-257, 302-244.
13. Burton, J., Ijjaali, I., Petitet, F., Michel, A., & Vercauteren, D. P. (2009). Virtual screening for cytochromes: Successes of machine learning filters. Combinational Chemistry and High Throughput Screening, 12(4), 369-382. doi:10.2174/138620709788167935
14. Carlson, H. A., Masukawa, K. M., Rubins, K., Bushman, F. D., Jorgensen, W. L., & Lins, R. D. (2000). Developing a dynamic pharmacophore model for HIV-1 integrase. Journal of Medicinal Chemistry, 43(11), 2100-2114. doi:10.1021/jm990322h
15. Carosati, E., Mannhold, R., Wahl, P., Hansen, J. B., Fremming, T., & Zamora, I. (2007). Virtual screening for novel openers of pancreatic K(ATP) channels. Journal of Medicinal Chemistry, 50(9), 2117-2126. doi:10.1021/jm061440p
16. Castilho, M. S., Postigo, M. P., de Paula, C. B., Montanari, C. A., Oliva, G., & Andricopulo, A. D. (2006). Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors. Bioorganic & Medicinal Chemistry, 14(2), 516-527. doi:10.1016/j.bmc.2005.08.055
17. Cavasotto, C. N., & Phatak, S. S. (2009). Homology modeling in drug discovery: Current trends and applications. Drug Discovery Today, 14(13-14), 676-683. doi:10.1016/j.drudis.2009.04.006
18. C.B.R., Subramanian, J. & Sharma, S.D. (2009). Managing protein flexibility in docking and its applications. Drug Discovery Today, 14(7-8), 394-400. doi:10.1016/j.drudis.2009.01.003
19. Charifson, P. S., Corkery, J. J., Murcko, M. A., & Walters, W. P. (1999). Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. Journal of Medicinal Chemistry, 42(25), 5100-5109. doi:10.1021/jm990352k
20. Chen, C. Y., Chang, Y. H., Bau, D. T., Huang, H. J., Tsai, F. J., & Tsai, C. H. (2009). Ligand-based dual target drug design for H1N1: Swine flu-a preliminary first study. Journal of Biomolecular Structure & Dynamics, 27(2), 171-178.
21. Chen, H., Lyne, P. D., Giordanetto, F., Lovell, T., & Li, J. (2006). On evaluating molecular-docking methods for pose prediction and enrichment factors. Journal of Chemical Information and Modeling, 46(1), 401-415. doi:10.1021/ci0503255
22. Chen, Z., Li, H. L., Zhang, Q. J., Bao, X. G., Yu, K. Q., & Luo, X. M. (2009). Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets. Acta Pharmacologica Sinica, 30(12), 1694-1708. doi:10.1038/aps.2009.159
23. Cole, J. C., Murray, C. W., Nissink, J. W., Taylor, R. D., & Taylor, R. (2005). Comparing proteinligand docking programs is difficult. Proteins, 60(3), 325-332. doi:10.1002/prot.20497
24. Cramer, R. D. III, Patterson, D. E., & Bunce, J. D. (1989). Recent advances in comparative molecular field analysis (CoMFA). Progress in Clinical and Biological Research, 291, 161-165.
25. Cruciani, G., Pastor, M., & Guba, W. (2000). VolSurf: A new tool for the pharmacokinetic optimization of lead compounds. European Journal of Pharmaceutical Sciences, 11(Suppl 2), S29-S39. doi:10.1016/S0928-0987(00)00162-7
26. DesJarlais, R. L., Seibel, G. L., Kuntz, I. D., Furth, P. S., Alvarez, J. C., & Ortiz de Montellano, P. R. (1990). Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proceedings of the National Academy of Sciences of the United States of America, 87(17), 6644-6648. doi:10.1073/pnas.87.17.6644
27. Doman, T. N., McGovern, S. L., Witherbee, B. J., Kasten, T. P., Kurumbail, R., & Stallings, W. C. (2002). Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. Journal of Medicinal Chemistry, 45(11), 2213-2221. doi:10.1021/jm010548w
28. Drews, J. (2000). Drug discovery: A historical perspective. Science, 287(5460), 1960-1964. doi:10.1126/science.287.5460.1960
29. Eldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V., & Mee, R. P. (1997). Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of Computer-Aided Molecular Design, 11(5), 425-445. doi:10.1023/A:1007996124545
30. Feher, M. (2006). Consensus scoring for proteinligand interactions. Drug Discovery Today, 11(9-10), 421-428. doi:10.1016/j.drudis.2006.03.009
31. Fischer, E. (1894). Einfluss der Configuration auf die Wirkung der Enzyme. Ber. Dtsch. Chem. Ges., 27, 2984-2993.
32. Fishman, M. C., & Porter, J.A. (2005). Pharmaceuticals: Anew grammar for drug discovery. Nature, 437(7058), 491-493. doi:10.1038/437491a
33. Franke, L., Schwarz, O., Muller-Kuhrt, L., Hoernig, C., Fischer, L., & George, S. (2007). Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. Journal of Medicinal Chemistry, 50(11), 2640-2646. doi:10.1021/jm060655w
34. Free, S. M. (1964). A mathematical contribution to structure-activity studies. Journal of Medicinal Chemistry, 7, 395-399. doi:10.1021/jm00334a001
35. Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., & Mainz, D. T. (2004). Glide:Anew approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739-1749. doi:10.1021/jm0306430
36. Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., & Halgren, T. A. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177-6196. doi:10.1021/jm051256o
37. Gohlke, H., Hendlich, M., & Klebe, G. (2000). Knowledge-based scoring function to predict protein-ligand interactions. Journal of Molecular Biology, 295(2), 337-356. doi:10.1006/jmbi.1999.3371
38. Good, A. C., Krystek, S. R., & Mason, J. S. (2000). High-throughput and virtual screening: Core lead discovery technologies move towards integration. Drug Discovery Today, 5(12Suppl 1), 61-69. doi:10.1016/S1359-6446(00)00015-5
39. Goodford, P. J. (1985).Acomputational procedure for determining energetically favorable binding sites on biologically important macromolecules. Journal of Medicinal Chemistry, 28(7), 849-857. doi:10.1021/jm00145a002
40. Goodsell, D. S., & Olson, A. J. (1990). Automated docking of substrates to proteins by simulated annealing. Proteins, 8(3), 195-202. doi:10.1002/prot.340080302
41. Guvench, O., & MacKerell, A. D. Jr. (2008). Comparison of protein force fields for molecular dynamics simulations. Methods in Molecular Biology (Clifton, N.J.), 443, 63-88. doi:10.1007/978-1-59745-177-2_4
42. Halperin, I., Ma, B., Wolfson, H., & Nussinov, R. (2002). Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins, 47(4), 409-443. doi:10.1002/prot.10115
43. Hansch, C. (1964). p-s-p Analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86, 1616-1626. doi:10.1021/ja01062a035
44. Hart, T. N., & Read, R. J. (1992). A multiple-start Monte Carlo docking method. Proteins, 13(3), 206-222. doi:10.1002/prot.340130304
45. Hert, J., Willett, P., Wilton, D. J., Acklin, P., Azzaoui, K., & Jacoby, E. (2004). Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. Organic & Biomolecular Chemistry, 2(22), 3256-3266. doi:10.1039/b409865j
46. Hoffren, A. M., Murray, C. M., & Hoffmann, R. D. (2001). Structure-based focusing using pharmacophores derived from the active site of 17beta-hydroxysteroid dehydrogenase. Current Pharmaceutical Design, 7(7), 547-566. doi:10.2174/1381612013397870
47. Hopkins, A. L., & Groom, C. R. (2002). The druggable genome. Nature Reviews. Drug Discovery, 1(9), 727-730. doi:10.1038/nrd892
48. Horvath, D. (1997). A virtual screening approach applied to the search for trypanothione reductase inhibitors. Journal of Medicinal Chemistry, 40(15), 2412-2423. doi:10.1021/jm9603781
49. Jones, G., Willett, P., & Glen, R. C. (1995a). A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. Journal of Computer-Aided Molecular Design, 9(6), 532-549. doi:10.1007/BF00124324
50. Jones, G., Willett, P., & Glen, R. C. (1995b). Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. Journal of Molecular Biology, 245(1), 43-53. doi:10.1016/S0022-2836(95)80037-9
51. Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3), 727-748. doi:10.1006/jmbi.1996.0897
52. Jorgensen, W. L. (2004). The many roles of computation in drug discovery. Science, 303(5665), 1813-1818. doi:10.1126/science.1096361
53. Kim, S. Y., Lee, Y. S., Kang, T., Kim, S., & Lee, J. (2006). Pharmacophore-based virtual screening: The discovery of novel methionyl-tRNA synthetase inhibitors. Bioorganic & Medicinal Chemistry Letters, 16(18), 4898-4907. doi:10.1016/j.bmcl.2006.06.057
54. Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews. Drug Discovery, 3(11), 935-949. doi:10.1038/nrd1549
55. Knegtel, R. M., Kuntz, I. D., & Oshiro, C. M. (1997). Molecular docking to ensembles of protein structures. Journal of Molecular Biology, 266(2), 424-440. doi:10.1006/jmbi.1996.0776
56. Kramer, A., Horn, H. W., & Rice, J. E. (2003). Fast 3D molecular superposition and similarity search in databases of flexible molecules. Journal of Computer-Aided Molecular Design, 17(1), 13-38. doi:10.1023/A:1024503712135
57. Kramer, B., Rarey, M., & Lengauer, T. (1999). Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins, 37(2), 228-241. doi:10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8
58. Krovat, E. M., Fruhwirth, K. H., & Langer, T. (2005). Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa. Journal of Chemical Information and Modeling, 45(1), 146-159. doi:10.1021/ci049778k
59. Krovat, E. M., & Langer, T. (2004). Impact of scoring functions on enrichment in dockingbased virtual screening: An application study on renin inhibitors. Journal of Chemical Information and Computer Sciences, 44(3), 1123-1129. doi:10.1021/ci0342728
60. Kuntz, I. D. (1992). Structure-based strategies for drug design and discovery. Science, 257(5073), 1078-1082. doi:10.1126/science.257.5073.1078
61. Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982). A geometric approach to macromolecule-ligand interactions. Journal of Molecular Biology, 161(2), 269-288. doi:10.1016/0022-2836(82)90153-X
62. Lahana, R. (1999). How many leads from HTS? Drug Discovery Today, 4(10), 447-448. doi:10.1016/S1359-6446(99)01393-8
63. Leach, A.R., Gillet, V.J., Lewis, R.A. & Taylor, R. (2009). Three-dimensional pharmacophore methods in drug discovery. Journal of Medical Chemistry.
64. Lemmen, C., & Lengauer, T. (2000).Computational methods for the structural alignment of molecules. Journal of Computer-Aided Molecular Design, 14(3), 215-232. doi:10.1023/A:1008194019144
65. Lemmen, C., Lengauer, T., & Klebe, G. (1998). FLEXS: A method for fast flexible ligand superposition. Journal of Medicinal Chemistry, 41(23), 4502-4520. doi:10.1021/jm981037l
66. Li, H. F., Lu, T., Zhu, T., Jiang, Y. J., Rao, S. S., & Hu, L. Y. (2009). Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas. European Journal of Medicinal Chemistry, 44(3), 1240-1249. doi:10.1016/j.ejmech.2008.09.016
67. Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1-3), 3-26. doi:10.1016/S0169-409X(00)00129-0
68. Liu, M., & Wang, S. (1999). MCDOCK: A Monte Carlo simulation approach to the molecular docking problem. Journal of ComputerAided Molecular Design, 13(5), 435-451. doi:10.1023/A:1008005918983
69. Lyne, P. D. (2002). Structure-based virtual screening: An overview. Drug Discovery Today, 7(20), 1047-1055. doi:10.1016/S1359-6446(02)02483-2
70. Mailman, R.B. & Murthy, V. (2009). Third generation antipsychotic drugs: Partial agonism or receptor functional selectivity? Current Pharmaceutical Design.
71. Mandal, S., Moudgil, M., & Mandal, S. K. (2009). Rational drug design. European Journal of Pharmacology, 625(1-3), 90-100. doi:10.1016/j.ejphar.2009.06.065
72. Martin, Y. C. (2005). A bioavailability score. Journal of Medicinal Chemistry, 48, 3164-3170. doi:10.1021/jm0492002
73. Martin, Y. C., Bures, M. G., Danaher, E. A., DeLazzer, J., Lico, I., & Pavlik, P.A. (1993).Afast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. Journal of Computer-Aided Molecular Design, 7(1), 83-102. doi:10.1007/BF00141577
74. McGann, M. R., Almond, H. R., Nicholls, A., Grant, J. A., & Brown, F. K. (2003). Gaussian docking functions. Biopolymers, 68(1), 76-90. doi:10.1002/bip.10207
75. Mestres, J., Rohrer, D.C. & Maggiora, G.M. (1997). A molecular field-based similarity approach to pharmacophoric pattern recognition. Journal of Molecular Graphics and Modelling, 15(2), 114-121, 103-116.
76. Miller, M. D., Kearsley, S. K., Underwood, D. J., & Sheridan, R. P. (1994). FLOG: A system to select 'quasi-flexible' ligands complementary to a receptor of known three-dimensional structure. Journal of Computer-Aided Molecular Design, 8(2), 153-174. doi:10.1007/BF00119865
77. Mishra, N., Basu, A., Jayaprakash, V., Sharon, A., Basu, M., & Patnaik, K. K. (2009). Structure based virtual screening of GSK-3beta: importance of protein flexibility and induced fit. Bioorganic & Medicinal Chemistry Letters, 19(19), 5582-5585. doi:10.1016/j.bmcl.2009.08.042
78. Mizutani, M. Y., Tomioka, N., & Itai, A. (1994). Rational automatic search method for stable docking models of protein and ligand. Journal of Molecular Biology, 243(2), 310-326. doi:10.1006/jmbi.1994.1656
79. Muegge, I. (2006). PMF scoring revisited. Journal of Medicinal Chemistry, 49(20), 5895-5902. doi:10.1021/jm050038s
80. Naylor, E., Arredouani, A., Vasudevan, S. R., Lewis, A. M., Parkesh, R., & Mizote, A. (2009). Identification of a chemical probe for NAADP by virtual screening. Nature Chemical Biology, 5(4), 220-226. doi:10.1038/nchembio.150
81. Nettles, J. H., Jenkins, J. L., Williams, C., Clark, A. M., Bender, A., & Deng, Z. (2007). Flexible 3D pharmacophores as descriptors of dynamic biological space. Journal of Molecular Graphics & Modelling, 26(3), 622-633. doi:10.1016/j.jmgm.2007.02.005
82. Neves, M. A., Dinis, T. C., Colombo, G., & Sa e Melo, M. L. (2009). Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors. Journal of Medicinal Chemistry, 52(1), 143-150. doi:10.1021/jm800945c
83. Norinder, U. (2005). In silico modelling of ADMET-a mini review of work from 2000 to 2004. SAR and QSAR in Environmental Research, 16, 1-11. doi:10.1080/10629360412331319835
84. Oda, A., Tsuchida, K., Takakura, T., Yamaotsu, N., & Hirono, S. (2006). Comparison of consensus scoring strategies for evaluating computational models of protein-ligand complexes. Journal of Chemical Information and Modeling, 46(1), 380-391. doi:10.1021/ci050283k
85. Osterberg, F., Morris, G. M., Sanner, M. F., Olson, A. J., & Goodsell, D. S. (2002). Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity inAutoDock. Proteins, 46(1), 34-40. doi:10.1002/prot.10028
86. Patterson, D. E., Cramer, R. D., Ferguson, A. M., Clark, R. D., & Weinberger, L. E. (1996). Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. Journal of Medicinal Chemistry, 39(16), 3049-3059. doi:10.1021/jm960290n
87. Philippopoulos, M., & Lim, C. (1999). Exploring the dynamic information content of a protein NMR structure: Comparison of a molecular dynamics simulation with the NMR and Xray structures of Escherichia coli ribonuclease HI. Proteins, 36(1), 87-110. doi:10.1002/(SICI)1097-0134(19990701)36:1<87::AID-PROT8>3.0.CO;2-R
88. Pitman, M. C., Huber, W. K., Horn, H., Kramer, A., Rice, J. E., & Swope, W. C. (2001). FLASHFLOOD: A 3D field-based similarity search and alignment method for flexible molecules. Journal of Computer-Aided Molecular Design, 15(7), 587-612. doi:10.1023/A:1011921423829
89. Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996). A fast flexible docking method using an incremental construction algorithm. Journal of Molecular Biology, 261(3), 470-489. doi:10.1006/jmbi.1996.0477
90. Reddy, A. S., Pati, S. P., Kumar, P. P., Pradeep, H. N., & Sastry, G. N. (2007). Virtual screening in drug discovery-a computational perspective. Current Protein & Peptide Science, 8(4), 329-351. doi:10.2174/138920307781369427
91. Rognan, D., Lauemoller, S. L., Holm, A., Buus, S., & Tschinke, V. (1999). Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. Journal of Medicinal Chemistry, 42(22), 4650-4658. doi:10.1021/jm9910775
92. Rollinger, J. M., Haupt, S., Stuppner, H., & Langer, T. (2004). Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example. Journal of Chemical Information and Computer Sciences, 44(2), 480-488. doi:10.1021/ci030031o
93. Rollinger, J. M., Hornick, A., Langer, T., Stuppner, H., & Prast, H. (2004). Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. Journal of Medicinal Chemistry, 47(25), 6248-6254. doi:10.1021/jm049655r
94. Schneider, G., & Bohm, H. J. (2002). Virtual screening and fast automated docking methods. Drug Discovery Today, 7(1), 64-70. doi:10.1016/S1359-6446(01)02091-8
95. Sciabola, S., Morao, I., & de Groot, M. J. (2007). Pharmacophoric fingerprint method (TOPP) for 3D-QSAR modeling: Application to CYP2D6 metabolic stability. Journal of Chemical Information and Modeling, 47(1), 76-84. doi:10.1021/ci060143q
96. Sharff, A., & Jhoti, H. (2003). High-throughput crystallography to enhance drug discovery. Current Opinion in Chemical Biology, 7(3), 340-345. doi:10.1016/S1367-5931(03)00062-0
97. Shoichet, B. K., Stroud, R. M., Santi, D. V., Kuntz, I. D., & Perry, K. M. (1993). Structure-based discovery of inhibitors of thymidylate synthase. Science, 259(5100), 1445-1450. doi:10.1126/science.8451640
98. Sirois, S., Wei, D. Q., Du, Q., & Chou, K. C. (2004). Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points. Journal of Chemical Information and Computer Sciences, 44(3), 1111-1122. doi:10.1021/ci034270n
99. Stahura, F. L., & Bajorath, J. (2004). Virtual screening methods that complement HTS. Combinatorial Chemistry & High Throughput Screening, 7(4), 259-269.
100. Sun, H. (2008). Pharmacophore-based virtual screening. Current Medicinal Chemistry, 15(10), 1018-1024. doi:10.2174/092986708784049630
101. Szymkowski, D. E. (2005). Creating the next generation of protein therapeutics through rational drug design. Current Opinions in Drug Discovery and Development, 8(5), 590-600.
102. Tao, P., & Lai, L. (2001). Protein ligand docking based on empirical method for binding affinity estimation. Journal of ComputerAided Molecular Design, 15(5), 429-446. doi:10.1023/A:1011188704521
103. Taylor, J. S., & Burnett, R. M. (2000). DARWIN: A program for docking flexible molecules. Proteins, 41(2), 173-191. doi:10.1002/1097-0134(20001101)41:2<173::AID-PROT30>3.0.CO;2-3
104. Terp, G. E., Johansen, B. N., Christensen, I. T., & Jorgensen, F. S. (2001). A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities. Journal of Medicinal Chemistry, 44(14), 2333-2343. doi:10.1021/jm001090l
105. Thompson, D. C., Humblet, C., & Joseph-McCarthy, D. (2008). Investigation of MM-PBSA rescoring of docking poses. Journal of Chemical Information and Modeling, 48(5), 1081-1091. doi:10.1021/ci700470c
106. Tintori, C., Magnani, M., Schenone, S., & Botta, M. (2009). Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors. European Journal of Medicinal Chemistry, 44(3), 990-1000. doi:10.1016/j.ej-mech.2008.07.002
107. Totrov, M., & Abagyan, R. (1997). Flexible protein-ligand docking by global energy optimization in internal coordinates. Proteins, (Supplement 1), 215-220. doi:10.1002/(SICI)1097-0134(1997)1+<215::AID-PROT29>3.0.CO;2-Q
108. Vangrevelinghe, E., Zimmermann, K., Schoepfer, J., Portmann, R., Fabbro, D., & Furet, P. (2003). Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking. Journal of Medicinal Chemistry, 46(13), 2656-2662. doi:10.1021/jm030827e
109. Varady, J., Wu, X., Fang, X., Min, J., Hu, Z., & Levant, B. (2003). Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: Discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach. Journal of Medicinal Chemistry, 46(21), 4377-4392. doi:10.1021/jm030085p
110. Velec, H. F., Gohlke, H., & Klebe, G. (2005). DrugScore(CSD)-knowledge-based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction. Journal of Medicinal Chemistry, 48(20), 6296-6303. doi:10.1021/jm050436v
111. Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003). Improved protein-ligand docking using GOLD. Proteins, 52(4), 609-623. doi:10.1002/prot.10465
112. Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157-1174. doi:10.1002/jcc.20035
113. Wang, R., Lai, L., & Wang, S. (2002). Further development and validation of empirical scoring functions for structure-based binding affinity prediction. Journal of Computer-AidedMolecular Design, 16(1), 11-26. doi:10.1023/A:1016357811882
114. Warren, G. L., Andrews, C. W., Capelli, A. M., Clarke, B., LaLonde, J., & Lambert, M. H. (2006). A critical assessment of docking programs and scoring functions. Journal of Medicinal Chemistry, 49(20), 5912-5931. doi:10.1021/jm050362n
115. Welch, W., Ruppert, J., & Jain, A. N. (1996). Hammerhead: Fast, fully automated docking of flexible ligands to protein binding sites. Chemistry & Biology, 3(6), 449-462. doi:10.1016/S1074-5521(96)90093-9
116. Westerfors, M., Tedebark, U., Andersson, H. O., Ohrman, S., Choudhury, D., & Ersoy, O. (2003). Structure-based discovery of a new affinity ligand to pancreatic alpha-amylase. Journal of Molecular Recognition, 16(6), 396-405. doi:10.1002/jmr.626
117. Willett, P. (2006). Similarity-based virtual screening using 2D fingerprints. Drug Discovery Today, 11(23-24), 1046-1053. doi:10.1016/j.drudis.2006.10.005
118. Wolber, G., & Langer, T. (2005). LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling, 45(1), 160-169. doi:10.1021/ci049885e
119. Zhou, Z., Felts, A. K., Friesner, R. A., & Levy, R. M. (2007). Comparative performance of several flexible docking programs and scoring functions: enrichment studies for a diverse set of pharmaceutically relevant targets. Journal of Chemical Information and Modeling, 47(4), 1599-1608. doi:10.1021/ci7000346
120. Zoete, V., Grosdidier, A., & Michielin, O. (2009). Docking, virtual high throughput screening and in silico fragment-based drug design. Journal of Cellular and Molecular Medicine, 13(2), 238-248. doi:10.1111/j.1582-4934.2008.00665.x